Mission: Microbiome, a new novel that makes microbiome research accessible to the general public
9 Jul 2025by GMFH Editing Team
The human microbiome has captured the interest of researchers and the lay public. Patrick Veiga's new novel, Mission: Microbiome – Metchnikoff’s Legacy, explores how gut microbiome research could pave the way for better planetary health, from the first probiotics to groundbreaking innovations poised to transform the future of medicine and nutrition.
What happens in the gut doesn’t stay in the gut: the gut-organ axes at work
25 Jun 2025by GMFH Editing Team
Emerging studies support the relationship between the human gut microbiome and organ function outside the gut. Find out more about the knowns and unknowns on how the gut communicates with other parts of the body, involving the gut, the brain, the lungs, the skin, and even the heart, and why it matters to your health.
How what you eat, the medications you take, and where you live shape your gut microbiota
11 Jun 2025by Giovana Martucelli
Over two intense days of conference, specialists shared the latest research findings and their experiences in both research and clinical practice, exploring how everyday factors influence the composition of the gut microbiota and impact our health. Here, we bring you the key insights from the event.

Stay tuned to our latest news
Food 4 Gut Health news
Digestive Disease Week 2025 featured recent basic, translational, and clinical research into the microbiome. Find out more about the main takeaways relevant for your clinical practice selected by GMFH editors.
What’s on your plate? In the future, your gut microbiota will shape your doctor’s dietary advice
1 Sep 2025by Cristina Sáez
The gut microbiome influences how we respond to food and not all nutrients benefit us equally, something we’ve known for a while. A new review article delves into how our gut microbiome shapes the impact of diet on human health, leading to rethinking current nutrition guidelines.
Research & Practice news
Digestive Disease Week 2025 featured recent basic, translational, and clinical research into the microbiome. Find out more about the main takeaways relevant for your clinical practice selected by GMFH editors.
Precision therapy in Crohn’s disease: Why the microbiome should be part of the equation
25 Aug 2025by Konstantina Zafeiropoulou
Crohn’s disease is an immune-mediated disease without a cure. While current guideline-based therapies are immune-directed therapies (small molecules and biologics), recent advances in understanding how the gut microbiome changes precede and drive disease offer potential for developing personalized therapeutics.
Prebiotics have been widely researched in the context of gastrointestinal conditions and might hold potential to influence cognition outcomes by modulating the microbiota-gut-brain axis. A new randomised controlled trial in individuals aged over 60s showed that a prebiotic blend (inulin and fructo-oligosaccharides) is well tolerated and may improve cognition compared with a placebo.